Clinical Trial Update: Incidence/Magnitude-Haemorrhagic Progression-Cerebral Contusions and Identification (ID) of Safety Issues After Traumatic Brain Injury

View source ↗

Summary

A completed clinical trial sponsored by Novo Nordisk evaluates the incidence and magnitude of hemorrhagic progression in cerebral contusions after traumatic bra…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acquired Bleeding Disorder
• Traumatic Brain Injury

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Acquired Bleeding Disorder, Trauma | Status: COMPLETED